NLRP3 and familial dilated cardiomyopathy: Plasma levels of IL-1β and IL-18 were also significantly higher in DCM patients, indicating that the NLRP3 inflammasome is activated in DCM and is likely involved in promoting cardiac dysfunction (100, 101).